Inflammatory pathways in the early steps of colorectal cancer development

World Journal of Gastroenterology

Volumn , Issue 29, 2014, Pages 9716-9731

  Mariani, Francesco ^a   Sena, Paola ^a   Roncucci, Luca ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Aberrant crypt foci; Apoptosis; Autophagy; Colorectal carcinogenesis; Hypoxia; Inflammation; Myeloperoxidase

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; ARGINASE; CD59 ANTIGEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 23; LIPID; LIPOXIN; LONG CHAIN FATTY ACID COENZYME A LIGASE; MITOCHONDRIAL TRANSCRIPTION FACTOR A; MYELOPEROXIDASE; NEUTROPHIL COLLAGENASE; REACTIVE OXYGEN METABOLITE; RESOLVIN; SCLEROPROTEIN; SIALYL LEWIS X ANTIGEN; SIRTUIN 1; SIRTUIN 3; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; AUTACOID; SIRTUIN; ARACHIDONIC ACID; GALECTIN; ICOSANOID; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; KELCH LIKE ECH ASSOCIATED PROTEIN 1; LEUKOTRIENE B4; PROSTAGLANDIN SYNTHASE; PROTEIN; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN;

ABERRANT CRYPT FOCUS; AEROBIC METABOLISM; ANAEROBIC METABOLISM; APOPTOSIS; AUTOPHAGY; CARCINOGENESIS; CELL PROLIFERATION; CELL REGENERATION; COLORECTAL CANCER; DNA DAMAGE; EPITHELIUM CELL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY CELL; MACROPHAGE; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; RECTUM MUCOSA; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STROMA CELL; TISSUE INJURY; TUMOR MICROENVIRONMENT; ANIMAL; CANCER STEM CELL; CELL HYPOXIA; CELL TRANSFORMATION; COLON; COLORECTAL NEOPLASMS; COMPLICATION; IMMUNOLOGY; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; RISK FACTOR; ARTICLE; COLON CARCINOGENESIS; WNT SIGNALING PATHWAY;

ANIMALS; APOPTOSIS; AUTOPHAGY; CELL HYPOXIA; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLON; COLORECTAL NEOPLASMS; HUMANS; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; NEOPLASTIC STEM CELLS; NF-KAPPA B; OXIDATIVE STRESS; RISK FACTORS; SIGNAL TRANSDUCTION; SIRTUINS; STROMAL CELLS; TUMOR MICROENVIRONMENT;

EID: 84905828174     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i29.9716     Document Type: Review

References (144)

1. Nathan CF. Secretory products of macrophages. J Clin Invest 1987; 79: 319-326 [PMID: 3543052]
2. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969 [PMID: 19029990 DOI: 10.1038/nri2448]
3. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23: 549-555 [PMID: 12401408]
4. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35 [PMID: 12511873]
5. Biswas SK, Sica A, Lewis CE. Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J Immunol 2008; 180: 2011-2017 [PMID: 18250403]
6. Solinas G, Germano G, Mantovani A, Allavena P. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 2009; 86: 1065-1073 [PMID: 19741157 DOI: 10.1189/jlb.0609385]
7. McKenzie BS, Kastelein RA, Cua DJ. Understanding the IL-23-IL-17 immune pathway. Trends Immunol 2006; 27: 17-23 [PMID: 16290228]
8. Stark MA, Huo Y, Burcin TL, Morris MA, Olson TS, Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005; 22: 285-294 [PMID: 15780986]
9. Rubino SJ, Geddes K, Girardin SE. Innate IL-17 and IL-22 responses to enteric bacterial pathogens. Trends Immunol 2012; 33: 112-118 [PMID: 22342740 DOI: 10.1016/j.it.2012.01.003]
10. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677-686 [PMID: 15530839]
11. Curran JN, Winter DC, Bouchier-Hayes D. Biological fate and clinical implications of arginine metabolism in tissue healing. Wound Repair Regen 2006; 14: 376-386 [PMID: 16939563]
12. Ganster RW, Taylor BS, Shao L, Geller DA. Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B. Proc Natl Acad Sci USA 2001; 98: 8638-8643 [PMID: 11438703]
13. Munder M, Eichmann K, Modolell M. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J Immunol 1998; 160: 5347-5354 [PMID: 9605134]
14. Lamagna C, Aurrand-Lions M, Imhof BA. Dual role of macrophages in tumor growth and angiogenesis. J Leukoc Biol 2006; 80: 705-713 [PMID: 16864600]
15. Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol 2007; 7: 255-266 [PMID: 17380156]
16. Miyazaki K, Ohmori K, Izawa M, Koike T, Kumamoto K, Furukawa K, Ando T, Kiso M, Yamaji T, Hashimoto Y, Suzuki A, Yoshida A, Takeuchi M, Kannagi R. Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancers. Cancer Res 2004; 64: 4498-4505 [PMID: 15231659]
17. Kawamura YI, Toyota M, Kawashima R, Hagiwara T, Suzuki H, Imai K, Shinomura Y, Tokino T, Kannagi R, Dohi T. DNA hypermethylation contributes to incomplete synthesis of carbohydrate determinants in gastrointestinal cancer. Gastroenterology 2008; 135: 142-151.e3 [PMID: 18485915 DOI: 10.1053/j.gastro.2008.03.031]
18. Miyazaki K, Sakuma K, Kawamura YI, Izawa M, Ohmori K, Mitsuki M, Yamaji T, Hashimoto Y, Suzuki A, Saito Y, Dohi T, Kannagi R. Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9. J Immunol 2012; 188: 4690-4700 [PMID: 22467657 DOI: 10.4049/jimmunol.1100605]
19. Lau D, Mollnau H, Eiserich JP, Freeman BA, Daiber A, Gehling UM, Brümmer J, Rudolph V, Münzel T, Heitzer T, Meinertz T, Baldus S. Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci USA 2005; 102: 431-436 [PMID: 15625114]
20. Winterbourn CC . Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid. Toxicology 2002; 181-182: 223-227 [PMID: 12505315]
21. Serhan CN. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 2007; 25: 101-137 [PMID: 17090225]
22. Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 2010; 10: 427-439 [PMID: 20498669 DOI: 10.1038/nri2779]
23. Leitch AE, Duffin R, Haslett C, Rossi AG. Relevance of granulocyte apoptosis to resolution of inflammation at the respiratory mucosa. Mucosal Immunol 2008; 1: 350-363 [PMID: 19079199 DOI: 10.1038/mi.2008.31]
24. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989; 83: 865-875 [PMID: 2921324]
25. Simon HU. Neutrophil apoptosis pathways and their modifications in inflammation. Immunol Rev 2003; 193: 101-110 [PMID: 12752675]
26. Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol 2005; 77: 598-625 [PMID: 15689384]
27. Roncucci L, Mora E, Mariani F, Bursi S, Pezzi A, Rossi G, Pedroni M, Luppi D, Santoro L, Monni S, Manenti A, Bertani A, Merighi A, Benatti P, Di Gregorio C, de Leon PM. Myelo-peroxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2008; 17: 2291-2297 [PMID: 18768495 DOI: 10.1158/1055-9965.EPI-08-0224]
28. Ravichandran KS. Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways. Immunity 2011; 35: 445-455 [PMID: 22035837 DOI: 10.1016/j.immuni.2011.09.004]
29. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002; 2: 965-975 [PMID: 12461569]
30. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001; 294: 1871-1875 [PMID: 11729303]
31. Ohd JF, Nielsen CK, Campbell J, Landberg G, Löfberg H, Sjölander A. Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas. Gastroenterology 2003; 124: 57-70 [PMID: 12512030]
32. Bortuzzo C, Hanif R, Kashfi K, Staiano-Coico L, Shiff SJ, Rigas B. The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells. Biochim Biophys Acta 1996; 1300: 240-246 [PMID: 8679690]
33. Tilley SL, Coffman TM, Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001; 108: 15-23 [PMID: 11435451]
34. Stenson WF . Prostaglandins and epithelial response to injury. Curr Opin Gastroenterol 2007; 23: 107-110 [PMID: 17268236]
35. Castellone MD, Teramoto H, Gutkind JS. Cyclooxygenase-2 and colorectal cancer chemoprevention: the beta-catenin connection. Cancer Res 2006; 66: 11085-11088 [PMID: 17145847]
36. Mutoh M, Watanabe K, Kitamura T, Shoji Y, Takahashi M, Kawamori T, Tani K, Kobayashi M, Maruyama T, Kobayashi K, Ohuchida S, Sugimoto Y, Narumiya S, Sugimura T, Wakabayashi K. Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis. Cancer Res 2002; 62: 28-32 [PMID: 11782353]
37. Sinicrope FA, Gill S. Role of cyclooxygenase-2 in colorectal cancer. Cancer Metastasis Rev 2004; 23: 63-75 [PMID: 15000150]
38. Moussalli MJ, Wu Y, Zuo X, Yang XL, Wistuba II, Raso MG, Morris JS, Bowser JL, Minna JD, Lotan R, Shureiqi I. Mechanistic contribution of ubiquitous 15-lipoxygenase-1 expression loss in cancer cells to terminal cell differentiation evasion. Cancer Prev Res (Phila) 2011; 4: 1961-1972 [PMID: 21881028 DOI: 10.1158/1940-6207.CAPR-10-0280]
39. Nixon JB, Kim KS, Lamb PW, Bottone FG, Eling TE. 15-Li-poxygenase-1 has anti-tumorigenic effects in colorectal cancer. Prostaglandins Leukot Essent Fatty Acids 2004; 70: 7-15 [PMID: 14643174]
40. Melstrom LG, Bentrem DJ, Salabat MR, Kennedy TJ, Ding XZ, Strouch M, Rao SM, Witt RC, Ternent CA, Talamonti MS, Bell RH, Adrian TA. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model. Clin Cancer Res 2008; 14: 6525-6530 [PMID: 18927292 DOI: 10.1158/1078-0432.CCR-07-4631]
41. Wasilewicz MP, Kołodziej B, Bojułko T, Kaczmarczyk M, Sulzyc-Bielicka V, Bielicki D, Ciepiela K. Overexpression of 5-lipoxygenase in sporadic colonic adenomas and a possible new aspect of colon carcinogenesis. Int J Colorectal Dis 2010; 25: 1079-1085 [PMID: 20549218 DOI: 10.1007/s00384-010-0980-z]
42. Lawrence T, Willoughby DA, Gilroy DW. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2002; 2: 787-795 [PMID: 12360216]
43. McMahon B, Mitchell S, Brady HR, Godson C. Lipoxins: revelations on resolution. Trends Pharmacol Sci 2001; 22: 391-395 [PMID: 11478982]
44. El Kebir D, József L, Pan W, Wang L, Petasis NA, Serhan CN, Filep JG. 15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury. Am J Respir Crit Care Med 2009; 180: 311-319 [PMID: 19483113 DOI: 10.1164/rccm.200810-1601OC]
45. Shureiqi I, Lippman SM. Lipoxygenase modulation to reverse carcinogenesis. Cancer Res 2001; 61: 6307-6312 [PMID: 11522616]
46. Orlando UD, Garona J, Ripoll GV, Maloberti PM, Solano ÁR, Avagnina A, Gomez DE, Alonso DF, Podestá EJ. The functional interaction between Acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target. PLoS One 2012; 7: e40794 [PMID: 22808264 DOI: 10.1371/journal.pone.0040794]
47. Maloberti PM, Duarte AB, Orlando UD, Pasqualini ME, Solano AR, López-Otín C, Podestá EJ. Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells. PLoS One 2010; 5: e15540 [PMID: 21085606 DOI: 10.1371/journal.pone.0015540]
48. Evans MD, Dizdaroglu M, Cooke MS. Oxidative DNA damage and disease: induction, repair and significance. Mutat Res 2004; 567: 1-61 [PMID: 15341901]
49. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010; 49: 1603-1616 [PMID: 20840865 DOI: 10.1016/j.freeradbiomed.2010.09.006]
50. Ferguson LR . Chronic inflammation and mutagenesis. Mutat Res 2010; 690: 3-11 [PMID: 20223251 DOI: 10.1016/j.mrfmmm.2010.03.007]
51. Lonkar P, Dedon PC. Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates. Int J Cancer 2011; 128: 1999-2009 [PMID: 21387284 DOI: 10.1002/ijc.25815]
52. DalleDonne I, Milzani A, Colombo R. H2O2-treated actin: assembly and polymer interactions with cross-linking proteins. Biophys J 1995; 69: 2710-2719 [PMID: 8599677]
53. Knaapen AM, Güngör N, Schins RP, Borm PJ, Van Schooten FJ. Neutrophils and respiratory tract DNA damage and mutagenesis: a review. Mutagenesis 2006; 21: 225-236 [PMID: 16870698]
54. Güngör N, Godschalk RW, Pachen DM, Van Schooten FJ, Knaapen AM. Activated neutrophils inhibit nucleotide excision repair in human pulmonary epithelial cells: role of myeloperoxidase. FASEB J 2007; 21: 2359-2367 [PMID: 17440118]
55. Meira LB, Bugni JM, Green SL, Lee CW, Pang B, Borenshtein D, Rickman BH, Rogers AB, Moroski-Erkul CA, McFaline JL, Schauer DB, Dedon PC, Fox JG, Samson LD. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest 2008; 118: 2516-2525 [PMID: 18521188 DOI: 10.1172/JCI35073]
56. Martín MJ, Jiménez MD, Motilva V. New issues about nitric oxide and its effects on the gastrointestinal tract. Curr Pharm Des 2001; 7: 881-908 [PMID: 11472246]
57. Seril DN, Liao J, Yang GY. Colorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitis. Mol Carcinog 2007; 46: 341-353 [PMID: 17219424]
58. Toullec A, Gerald D, Despouy G, Bourachot B, Cardon M, Lefort S, Richardson M, Rigaill G, Parrini MC, Lucchesi C, Bellanger D, Stern MH, Dubois T, Sastre-Garau X, Delattre O, Vincent-Salomon A, Mechta-Grigoriou F. Oxidative stress promotes myofibroblast differentiation and tumour spreading. EMBO Mol Med 2010; 2: 211-230 [PMID: 20535745 DOI: 10.1002/emmm.201000073]
59. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392-401 [PMID: 16572188]
60. Othman EM, Leyh A, Stopper H. Insulin mediated DNA damage in mammalian colon cells and human lymphocytes in vitro. Mutat Res 2013; 745-746: 34-39 [PMID: 23524287 DOI: 10.1016/j.mrfmmm.2013.03.006]
61. Woo DK, Green PD, Santos JH, D'Souza AD, Walther Z, Martin WD, Christian BE, Chandel NS, Shadel GS. Mitochondrial genome instability and ROS enhance intestinal tumorigenesis in APC(Min/+) mice. Am J Pathol 2012; 180: 24-31 [PMID: 22056359 DOI: 10.1016/j.ajpath.2011.10.003]
62. Nakayama Y, Yamauchi M, Minagawa N, Torigoe T, Izumi H, Kohno K, Yamaguchi K. Clinical significance of mitochondrial transcription factor A expression in patients with colorectal cancer. Oncol Rep 2012; 27: 1325-1330 [PMID: 22266811 DOI: 10.3892/or.2012.1640]
63. Rankin EB, Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 2008; 15: 678-685 [PMID: 18259193 DOI: 10.1038/cdd.2008.21]
64. Kaidi A, Qualtrough D, Williams AC, Paraskeva C. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res 2006; 66: 6683-6691 [PMID: 16818642]
65. Dang DT, Chen F, Gardner LB, Cummins JM, Rago C, Bunz F, Kantsevoy SV, Dang LH. Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts. Cancer Res 2006; 66: 1684-1936 [PMID: 16452228]
66. Lum JJ, Bui T, Gruber M, Gordan JD, DeBerardinis RJ, Covello KL, Simon MC, Thompson CB. The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev 2007; 21: 1037-1049 [PMID: 17437992]
67. López-Lázaro M. HIF-1: hypoxia-inducible factor or dysoxia-inducible factor? FASEB J 2006; 20: 828-832 [PMID: 16675839]
68. Chi JT, Wang Z, Nuyten DS, Rodriguez EH, Schaner ME, Salim A, Wang Y, Kristensen GB, Helland A, Børresen-Dale AL, Giaccia A, Longaker MT, Hastie T, Yang GP, van de Vijver MJ, Brown PO. Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med 2006; 3: e47 [PMID: 16417408]
69. Semenza GL, Roth PH, Fang HM, Wang GL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 1994; 269: 23757-23763 [PMID: 8089148]
70. Glebov OK, Rodriguez LM, Soballe P, DeNobile J, Cliatt J, Nakahara K, Kirsch IR. Gene expression patterns distinguish colonoscopically isolated human aberrant crypt foci from normal colonic mucosa. Cancer Epidemiol Biomarkers Prev 2006; 15: 2253-2262 [PMID: 17119054]
71. Ullah MS, Davies AJ, Halestrap AP. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem 2006; 281: 9030-9037 [PMID: 16452478]
72. Fukuda R, Zhang H, Kim JW, Shimoda L, Dang CV, Semenza GL. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 2007; 129: 111-122 [PMID: 17418790]
73. Nishikawa M, Oshitani N, Matsumoto T, Nishigami T, Arakawa T, Inoue M. Accumulation of mitochondrial DNA mutation with colorectal carcinogenesis in ulcerative colitis. Br J Cancer 2005; 93: 331-337 [PMID: 15956973]
74. Sui G, Zhou S, Wang J, Canto M, Lee EE, Eshleman JR, Montgomery EA, Sidransky D, Califano JA, Maitra A. Mitochondrial DNA mutations in preneoplastic lesions of the gastrointestinal tract: a biomarker for the early detection of cancer. Mol Cancer 2006; 5: 73 [PMID: 17166268]
75. Mariani F, Sena P, Marzona L, Riccio M, Fano R, Manni P, Gregorio CD, Pezzi A, Leon MP, Monni S, Pol AD, Roncucci L. Cyclooxygenase-2 and Hypoxia-Inducible Factor-1alpha protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis. Cancer Lett 2009; 279: 221-229 [PMID: 19268443 DOI: 10.1016/j.canlet.2009.02.001]
76. Yu JX, Cui L, Zhang QY, Chen H, Ji P, Wei HJ, Ma HY. Expression of NOS and HIF-1alpha in human colorectal carcinoma and implication in tumor angiogenesis. World J Gastroenterol 2006; 12: 4660-4664 [PMID: 16937436]
77. Li C, Hashimi SM, Cao S, Mellick AS, Duan W, Good D, Wei MQ. The mechanisms of chansu in inducing efficient apoptosis in colon cancer cells. Evid Based Complement Alternat Med 2013; 2013: 849054 [PMID: 23818933 DOI: 10.1155/2013/849054]
78. Giudice A, Montella M. Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention. Bioessays 2006; 28: 169-181 [PMID: 16435293]
79. Kikuchi N, Ishii Y, Morishima Y, Yageta Y, Haraguchi N, Itoh K, Yamamoto M, Hizawa N. Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance. Respir Res 2010; 11: 31 [PMID: 20298567 DOI: 10.1186/1465-9921-11-31]
80. Chan K, Kan YW. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc Natl Acad Sci USA 1999; 96: 12731-12736 [PMID: 10535991]
81. Enomoto A, Itoh K, Nagayoshi E, Haruta J, Kimura T, O'Connor T, Harada T, Yamamoto M. High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol Sci 2001; 59: 169-177 [PMID: 11134556]
82. Shelton P, Jaiswal AK. The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene? FASEB J 2013; 27: 414-423 [PMID: 23109674 DOI: 10.1096/fj.12-217257]
83. Shen H, Zhou S, Wang J. The paradoxical role of Nrf2 in tumor biology. Crit Rev Eukaryot Gene Expr 2013; 23: 37-47 [PMID: 23557336]
84. Cheung KL, Lee JH, Khor TO, Wu TY, Li GX, Chan J, Yang CS, Kong AN. Nrf2 knockout enhances intestinal tumorigenesis in Apc(min/+) mice due to attenuation of anti-oxidative stress pathway while potentiates inflammation. Mol Carcinog 2014; 53: 77-84 [PMID: 22911891 DOI: 10.1002/mc.21950]
85. Zhang L, Wang N, Zhou S, Ye W, Jing G, Zhang M. Propofol induces proliferation and invasion of gallbladder cancer cells through activation of Nrf2. J Exp Clin Cancer Res 2012; 31: 66 [PMID: 22901367 DOI: 10.1186/1756-9966-31-66]
86. Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J 2007; 404: 1-13 [PMID: 17447894]
87. Saunders LR, Verdin E. Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene 2007; 26: 5489-5504 [PMID: 17694089]
88. Zhang T, Kraus WL. SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions. Biochim Biophys Acta 2010; 1804: 1666-1675 [PMID: 19879981 DOI: 10.1016/j.bbapap.2009.10.022]
89. Qiu X, Brown K, Hirschey MD, Verdin E, Chen D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 2010; 12: 662-667 [PMID: 21109198 DOI: 10.1016/j.cmet.2010.11.015]
90. Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage J, Owens KM, Vassilopoulos A, Ozden O, Park SH, Singh KK, Abdulkadir SA, Spitz DR, Deng CX, Gius D. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 2010; 17: 41-52 [PMID: 20129246 DOI: 10.1016/j.ccr.2009.11.023]
91. Motilva V, García-Mauriño S, Talero E, Illanes M. New paradigms in chronic intestinal inflammation and colon cancer: role of melatonin. J Pineal Res 2011; 51: 44-60 [PMID: 21752096 DOI: 10.1111/j.1600-079X.2011]
92. Singh UP, Singh NP, Singh B, Hofseth LJ, Price RL, Nagarkatti M, Nagarkatti PS. Resveratrol (trans-3,5,4′-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-kappaB activation to abrogate dextran sulfate sodium-induced colitis. J Pharmacol Exp Ther 2010; 332: 829-839 [PMID: 19940103 DOI: 10.1124/jpet.109.160838]
93. Cui X, Jin Y, Hofseth AB, Pena E, Habiger J, Chumanevich A, Poudyal D, Nagarkatti M, Nagarkatti PS, Singh UP, Hofseth LJ. Resveratrol suppresses colitis and colon cancer associated with colitis. Cancer Prev Res (Phila) 2010; 3: 549-559 [PMID: 20332304 DOI: 10.1158/1940-6207.CAPR-09-0117]
94. Jung-Hynes B, Reiter RJ, Ahmad N. Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. J Pineal Res 2010; 48: 9-19 [PMID: 20025641 DOI: 10.1111/j.1600-079X.2009.00729.x]
95. Ford J, Jiang M, Milner J. Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival. Cancer Res 2005; 65: 10457-10463 [PMID: 16288037]
96. Nosho K, Shima K, Irahara N, Kure S, Firestein R, Baba Y, Toyoda S, Chen L, Hazra A, Giovannucci EL, Fuchs CS, Ogino S. SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Mod Pathol 2009; 22: 922-932 [PMID: 19430421 DOI: 10.1038/modpathol.2009.49]
97. Firestein R, Blander G, Michan S, Oberdoerffer P, Ogino S, Campbell J, Bhimavarapu A, Luikenhuis S, de Cabo R, Fuchs C, Hahn WC, Guarente LP, Sinclair DA. The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One 2008; 3: e2020 [PMID: 18414679 DOI: 10.1371/journal.pone.0002020]
98. Holloway KR, Calhoun TN, Saxena M, Metoyer CF, Kandler EF, Rivera CA, Pruitt K. SIRT1 regulates Dishevelled proteins and promotes transient and constitutive Wnt signaling. Proc Natl Acad Sci USA 2010; 107: 9216-9221 [PMID: 20439735 DOI: 10.1073/pnas.0911325107]
99. Kabra N, Li Z, Chen L, Li B, Zhang X, Wang C, Yeatman T, Coppola D, Chen J. SirT1 is an inhibitor of proliferation and tumor formation in colon cancer. J Biol Chem 2009; 284: 18210-18217 [PMID: 19433578 DOI: 10.1074/jbc.M109.000034]
100. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315: 1650-1659 [PMID: 3537791]
101. Haddow A. Molecular repair, wound healing, and carcinogenesis: tumor production a possible overhealing? Adv Cancer Res 1972; 16: 181-234 [PMID: 4563044]
102. Huber S, Gagliani N, Zenewicz LA, Huber FJ, Bosurgi L, Hu B, Hedl M, Zhang W, O'Connor W, Murphy AJ, Valenzuela DM, Yancopoulos GD, Booth CJ, Cho JH, Ouyang W, Abraham C, Flavell RA. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 2012; 491: 259-263 [PMID: 23075849 DOI: 10.1038/nature11535]
103. Zindl CL, Lai JF, Lee YK, Maynard CL, Harbour SN, Ouyang W, Chaplin DD, Weaver CT. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc Natl Acad Sci USA 2013; 110: 12768-12773 [PMID: 23781104 DOI: 10.1073/pnas.1300318110]
104. Erwig LP, Henson PM. Immunological consequences of apoptotic cell phagocytosis. Am J Pathol 2007; 171: 2-8 [PMID: 17591947]
105. Sylvia CJ . The role of neutrophil apoptosis in influencing tissue repair. J Wound Care 2003; 12: 13-16 [PMID: 12572231]
106. Koh TJ, DiPietro LA. Inflammation and wound healing: the role of the macrophage. Expert Rev Mol Med 2011; 13: e23 [PMID: 21740602 DOI: 10.1017/S1462399411001943]
107. Kettritz R, Xu YX, Kerren T, Quass P, Klein JB, Luft FC, Haller H. Extracellular matrix regulates apoptosis in human neutrophils. Kidney Int 1999; 55: 562-571 [PMID: 9987080]
108. Ginis I, Faller DV. Protection from apoptosis in human neutrophils is determined by the surface of adhesion. Am J Physiol 1997; 272: C295-C309 [PMID: 9038836]
109. López-Novoa JM, Nieto MA. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med 2009; 1: 303-314 [PMID: 20049734 DOI: 10.1002/emmm.200900043]
110. Egeblad M, Rasch MG, Weaver VM. Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol 2010; 22: 697-706 [PMID: 20822891 DOI: 10.1016/j.ceb.2010.08.015]
111. Gill SE, Parks WC. Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol 2008; 40: 1334-1347 [PMID: 18083622]
112. Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 2010; 30: 245-257 [PMID: 20665377 DOI: 10.1055/s-0030-1255354]
113. Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ. Collagen reorganization at the tumorstromal interface facilitates local invasion. BMC Med 2006; 4: 38 [PMID: 17190588]
114. Asano T, Tada M, Cheng S, Takemoto N, Kuramae T, Abe M, Takahashi O, Miyamoto M, Hamada J, Moriuchi T, Kondo S. Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma. J Surg Res 2008; 146: 32-42 [PMID: 17543340]
115. Sena P, Roncucci L, Marzona L, Mariani F, Maffei S, Manenti A, De Pol A. Altered expression of apoptosis biomarkers in human colorectal microadenomas. Cancer Epidemiol Biomarkers Prev 2010; 19: 351-357 [PMID: 20142237 DOI: 10.1158/1055-9965.EPI-09-0438]
116. Kapsoritakis AN, Kapsoritaki AI, Davidi IP, Lotis VD, Manolakis AC, Mylonis PI, Theodoridou AT, Germenis AE, Potamianos SP. Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease. BMC Gastroenterol 2008; 8: 55 [PMID: 19036126 DOI: 10.1186/1471-230X-8-55]
117. Lakatos G, Hritz I, Varga MZ, Juhász M, Miheller P, Cierny G, Tulassay Z, Herszényi L. The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases. Dig Dis 2012; 30: 289-295 [PMID: 22722554 DOI: 10.1159/000336995]
118. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011; 11: 723-737 [PMID: 21997792 DOI: 10.1038/nri3073]
119. Wynn TA, Barron L, Thompson RW, Madala SK, Wilson MS, Cheever AW, Ramalingam T. Quantitative assessment of macrophage functions in repair and fibrosis. Curr Protoc Immunol 2011; Chapter 14: Unit14.22 [PMID: 21462164 DOI: 10.1002/0471142735.im1422s93]
120. Berdowska I . Cysteine proteases as disease markers. Clin Chim Acta 2004; 342: 41-69 [PMID: 15026265]
121. Talieri M, Papadopoulou S, Scorilas A, Xynopoulos D, Arnogianaki N, Plataniotis G, Yotis J, Agnanti N. Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma. Cancer Lett 2004; 205: 97-106 [PMID: 15036666]
122. Gabbiani G . The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003; 200: 500-503 [PMID: 12845617]
123. Brenmoehl J, Miller SN, Hofmann C, Vogl D, Falk W, Schölmerich J, Rogler G. Transforming growth factor-beta 1 induces intestinal myofibroblast differentiation and modulates their migration. World J Gastroenterol 2009; 15: 1431-1442 [PMID: 19322915]
124. Xouri G, Christian S. Origin and function of tumor stroma fibroblasts. Semin Cell Dev Biol 2010; 21: 40-46 [PMID: 19944178 DOI: 10.1016/j.semcdb.2009.11.017]
125. Kwak JM, Lee HJ, Kim SH, Kim HK, Mok YJ, Park YT, Choi JS, Moon HY. Expression of protein S100A4 is a predictor of recurrence in colorectal cancer. World J Gastroenterol 2010; 16: 3897-3904 [PMID: 20712050]
126. Tsujino T, Seshimo I, Yamamoto H, Ngan CY, Ezumi K, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M. Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin Cancer Res 2007; 13: 2082-2090 [PMID: 17404090]
127. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004; 432: 324-331 [PMID: 15549094]
128. Okamoto R, Watanabe M. Molecular and clinical basis for the regeneration of human gastrointestinal epithelia. J Gastroenterol 2004; 39: 1-6 [PMID: 14767727]
129. Brown SL, Riehl TE, Walker MR, Geske MJ, Doherty JM, Stenson WF, Stappenbeck TS. Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury. J Clin Invest 2007; 117: 258-269 [PMID: 17200722]
130. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000; 103: 311-320 [PMID: 11057903]
131. Pinto D, Gregorieff A, Begthel H, Clevers H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev 2003; 17: 1709-1713 [PMID: 12865297]
132. Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman JR, Watkins DN, Beachy PA. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003; 425: 846-851 [PMID: 14520411]
133. Ramalho-Santos M, Melton DA, McMahon AP. Hedgehog signals regulate multiple aspects of gastrointestinal development. Development 2000; 127: 2763-2772 [PMID: 10821773]
134. Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC, Kroemer G. Anti- and pro-tumor functions of autophagy. Biochim Biophys Acta 2009; 1793: 1524-1532 [PMID: 19371598 DOI: 10.1016/j.bbamcr.2009.01.006]
135. White E, DiPaola RS. The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 2009; 15: 5308-5316 [PMID: 19706824 DOI: 10.1158/1078-0432.CCR-07-5023]
136. He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 2009; 43: 67-93 [PMID: 19653858 DOI: 10.1146/annurev-genet-102808-114910]
137. Vellai T, Takács-Vellai K, Sass M, Klionsky DJ. The regulation of aging: does autophagy underlie longevity? Trends Cell Biol 2009; 19: 487-494 [PMID: 19726187 DOI: 10.1016/j.tcb.2009.07.007]
138. Botti J, Djavaheri-Mergny M, Pilatte Y, Codogno P. Autophagy signaling and the cogwheels of cancer. Autophagy 2006; 2: 67-73 [PMID: 16874041]
139. Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y, Sou YS, Ueno I, Sakamoto A, Tong KI, Kim M, Nishito Y, Iemura S, Natsume T, Ueno T, Kominami E, Motohashi H, Tanaka K, Yamamoto M. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 2010; 12: 213-223 [PMID: 20173742 DOI: 10.1038/ncb2021]
140. Faraonio R, Vergara P, Di Marzo D, Pierantoni MG, Napolitano M, Russo T, Cimino F. p53 suppresses the Nrf2-dependent transcription of antioxidant response genes. J Biol Chem 2006; 281: 39776-39784 [PMID: 17077087]
141. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431: 461-466 [PMID: 15329734]
142. Luo JL, Kamata H, Karin M. IKK/NF-kappaB signaling: balancing life and death - a new approach to cancer therapy. J Clin Invest 2005; 115: 2625-2632 [PMID: 16200195]
143. Richmond A. Nf-kappa B, chemokine gene transcription and tumour growth. Nat Rev Immunol 2002; 2: 664-674 [PMID: 12209135]
144. Bharti AC, Aggarwal BB. Chemopreventive agents induce suppression of nuclear factor-kappaB leading to chemosensitization. Ann N Y Acad Sci 2002; 973: 392-395 [PMID: 12485899]